Chi‐I Chang

2.7k total citations
131 papers, 2.1k citations indexed

About

Chi‐I Chang is a scholar working on Molecular Biology, Plant Science and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Chi‐I Chang has authored 131 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 34 papers in Plant Science and 24 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Chi‐I Chang's work include Natural product bioactivities and synthesis (49 papers), Biological Activity of Diterpenoids and Biflavonoids (28 papers) and Phytochemistry and Biological Activities (25 papers). Chi‐I Chang is often cited by papers focused on Natural product bioactivities and synthesis (49 papers), Biological Activity of Diterpenoids and Biflavonoids (28 papers) and Phytochemistry and Biological Activities (25 papers). Chi‐I Chang collaborates with scholars based in Taiwan, Indonesia and Czechia. Chi‐I Chang's co-authors include Yueh‐Hsiung Kuo, Lih Kuo, James C. Liao, Chiy‐Rong Chen, Jue‐Liang Hsu, Hsueh‐Ling Cheng, Chen-Hsing Chou, Yun‐Wen Liao, Wen‐Ling Shih and Ming‐Huei Liao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Agricultural and Food Chemistry and Food Chemistry.

In The Last Decade

Chi‐I Chang

129 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi‐I Chang Taiwan 26 1.1k 409 311 256 223 131 2.1k
Halagowder Devaraj India 31 1.2k 1.1× 348 0.9× 175 0.6× 292 1.1× 113 0.5× 108 2.8k
Jeong‐Yeh Yang United States 31 1.4k 1.3× 545 1.3× 206 0.7× 220 0.9× 129 0.6× 80 3.1k
Toshiyuki Murakami Japan 28 1.4k 1.3× 659 1.6× 420 1.4× 176 0.7× 190 0.9× 69 2.5k
Carol S. Fink United States 27 1.2k 1.1× 456 1.1× 292 0.9× 150 0.6× 163 0.7× 50 2.8k
Wen‐Chin Yang Taiwan 32 1.1k 0.9× 676 1.7× 439 1.4× 695 2.7× 117 0.5× 101 3.2k
Mitsuo Jisaka Japan 23 771 0.7× 339 0.8× 260 0.8× 96 0.4× 126 0.6× 70 1.6k
Rui‐Dong Duan Sweden 32 2.0k 1.8× 236 0.6× 231 0.7× 209 0.8× 97 0.4× 87 3.2k
Hee‐Sung Chae South Korea 28 1.0k 0.9× 496 1.2× 122 0.4× 206 0.8× 70 0.3× 98 2.1k
Sumit Ghosh India 28 1.4k 1.2× 801 2.0× 298 1.0× 132 0.5× 85 0.4× 64 2.7k
Rabah Iratni United Arab Emirates 33 1.1k 1.0× 776 1.9× 131 0.4× 176 0.7× 106 0.5× 73 2.9k

Countries citing papers authored by Chi‐I Chang

Since Specialization
Citations

This map shows the geographic impact of Chi‐I Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐I Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐I Chang more than expected).

Fields of papers citing papers by Chi‐I Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐I Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐I Chang. The network helps show where Chi‐I Chang may publish in the future.

Co-authorship network of co-authors of Chi‐I Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐I Chang. A scholar is included among the top collaborators of Chi‐I Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐I Chang. Chi‐I Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Tain, You‐Lin, Chi‐I Chang, Chih‐Yao Hou, et al.. (2023). Dietary Resveratrol Butyrate Monoester Supplement Improves Hypertension and Kidney Dysfunction in a Young Rat Chronic Kidney Disease Model. Nutrients. 15(3). 635–635. 16 indexed citations
4.
Chen, Chiy‐Rong, et al.. (2022). Mechanistic Insights into the Inhibitory Activities of Chemical Constituents from the Fruits ofTerminalia boiviniion α‐Glucosidase. Chemistry & Biodiversity. 19(7). e202200137–e202200137. 2 indexed citations
6.
Chen, Pei-Chin, et al.. (2022). The anti-inflammatory properties of ethyl acetate fraction in ethanol extract from Sarcodia suiae sp. alleviates atopic dermatitis-like lesion in mice. Bioscience Biotechnology and Biochemistry. 86(5). 646–654. 8 indexed citations
7.
Chen, Po‐Chun, Chiy‐Rong Chen, Yueh‐Hsiung Kuo, et al.. (2022). Structure related α-glucosidase inhibitory activity and molecular docking analyses of phenolic compounds from Paeonia suffruticosa. Medicinal Chemistry Research. 31(2). 293–306. 11 indexed citations
9.
Chen, Yinbo, Jialin Guo, Shiming Li, et al.. (2022). Acetylation Enhances the Anticancer Activity and Oral Bioavailability of 5-Demethyltangeretin. International Journal of Molecular Sciences. 23(21). 13284–13284. 9 indexed citations
10.
Chang, Ching‐Dong, et al.. (2022). Tea Seed Kaempferol Triglycoside Attenuates LPS-Induced Systemic Inflammation and Ameliorates Cognitive Impairments in a Mouse Model. Molecules. 27(7). 2055–2055. 10 indexed citations
11.
Shih, Ming‐Kuei, You‐Lin Tain, C. C. Cheng, et al.. (2021). Separation and Identification of Resveratrol Butyrate Ester Complexes and Their Bioactivity in HepG2 Cell Models. International Journal of Molecular Sciences. 22(24). 13539–13539. 19 indexed citations
12.
Chen, Chiy‐Rong, et al.. (2021). In vitro antioxidant, antiglycation, and enzymatic inhibitory activity against α-glucosidase, α-amylase, lipase and HMG-CoA reductase of Terminalia boivinii Tul.. Biocatalysis and Agricultural Biotechnology. 39. 102235–102235. 6 indexed citations
13.
Hsu, Chien‐Ning, Chih‐Hsing Hung, Chih‐Yao Hou, Chi‐I Chang, & You‐Lin Tain. (2021). Perinatal Resveratrol Therapy to Dioxin-Exposed Dams Prevents the Programming of Hypertension in Adult Rat Offspring. Antioxidants. 10(9). 1393–1393. 25 indexed citations
14.
Hsu, Chien‐Ning, Chih‐Yao Hou, Chi‐I Chang, & You‐Lin Tain. (2021). Resveratrol Butyrate Ester Protects Adenine-Treated Rats against Hypertension and Kidney Disease by Regulating the Gut–Kidney Axis. Antioxidants. 11(1). 83–83. 28 indexed citations
15.
Wardani, Agustin Krisna, et al.. (2019). Anthraquinone Derivatives and its Antibacterial Properties from Paederia foetida Stems. The Natural Products Journal. 11(2). 193–199. 6 indexed citations
16.
Chang, Chi‐I, Huei‐Meei Su, Pei-Chin Chen, et al.. (2017). Anti-Inflammatory and Antinociceptive Effects of Ethyl Acetate Fraction of an Edible Red Macroalgae Sarcodia ceylanica. International Journal of Molecular Sciences. 18(11). 2437–2437. 21 indexed citations
17.
Chang, Chi‐I, Chien-Chih Chen, Che‐Yi Chao, et al.. (2016). Sesquiterpenoids and Diterpenoids from the Wood of Cunninghamia konishii and Their Inhibitory Activities against NO Production. Molecules. 21(4). 490–490. 1 indexed citations
18.
Huang, Guan‐Jhong, Hui‐Chi Huang, Yu‐Chang Chen, et al.. (2013). The Effect of the Aerial Part of Lindera akoensis on Lipopolysaccharides (LPS)-Induced Nitric Oxide Production in RAW264.7 Cells. International Journal of Molecular Sciences. 14(5). 9168–9181. 22 indexed citations
19.
Li, Fengyin, Chi‐I Chang, Chih‐Chien Hung, et al.. (2013). Concurrent Accumulation of Myricetin and Gallic Acid Putatively Responsible for the Umami Taste of a Specialized Old Oolong Tea. Journal of food and nutrition research. 1(6). 164–173. 7 indexed citations
20.
Huang, Hui‐Chi, et al.. (2013). Two Anti-inflammatory Steroidal Saponins from Dracaena angustifolia Roxb.. Molecules. 18(8). 8752–8763. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026